Financial Performance - Revenues for Q3 FY2026 increased 50.0% to $47.3 million, compared to $31.5 million in Q3 FY2025[2][9] - Gross profit rose 56.6% to $11.1 million, representing 23.6% of total revenues, up from 22.6% in the prior year[3][10] - Net income increased 31.7% to $0.5 million, or $0.01 per diluted share, compared to $0.4 million in the same quarter last year[3][12] - Adjusted EBITDA surged 118.0% to $3.8 million, compared to $1.7 million in Q3 FY2025[3][12] - Net sales for the three months ended October 31, 2025, were $47.269 million, a 50% increase from $31.523 million in the same period of 2024[27] - Gross profit for the nine months ended October 31, 2025, was $29.091 million, up 35.5% from $21.455 million in 2024[27] - Net income for the nine months ended October 31, 2025, was $3.054 million, a 44.8% increase from $2.111 million in 2024[29] Expenses and Liabilities - Operating expenses totaled $10.3 million, with a percentage of revenue increasing to 21.8% from 20.8% in the prior year[3][11] - Operating expenses for the three months ended October 31, 2025, totaled $10.313 million, compared to $6.550 million in the same period of 2024, reflecting a 57% increase[27] - Total liabilities increased to $34.436 million as of October 31, 2025, from $22.166 million as of January 31, 2025[24] Cash and Assets - Cash and cash equivalents grew to $18.1 million as of October 31, 2025, up from $7.2 million as of January 31, 2025[4][13] - Cash and cash equivalents increased to $18.068 million as of October 31, 2025, from $7.150 million at the beginning of the period[29] - Total current assets rose to $40.963 million as of October 31, 2025, compared to $21.877 million as of January 31, 2025[24] Acquisitions and Strategic Goals - The acquisition of Crown 1 added $56.8 million in revenue based on the 12 months ended June 28, 2025[4] - The company incurred $17.500 million for the acquisition of Crown I Enterprises, Inc.[29] - The strategic goal is to become a $1 billion deli prepared foods company, focusing on integration and capital allocation[8] Market and Product Development - The company secured new placements at Target and Food Lion, with shipments expected to begin in February and later this month, respectively[4][7] - New product development is underway, focusing on innovative technologies to enhance user experience[30] - Market expansion strategies are being implemented to increase the company's footprint in emerging markets[30] - The company is exploring potential acquisitions to bolster its market position and product offerings[30] Future Outlook - Management aims to lift consolidated corporate gross margins from the low-20% range to the mid-20% range over the next year[6] - The company provided a positive outlook for the next quarter, expecting continued revenue growth driven by new product launches[30] - The company aims to increase its market share by 15% over the next fiscal year[30] - The company plans to invest $450 million in research and development over the next year[30] Customer and Operational Metrics - Customer satisfaction metrics have improved, indicating a positive reception of recent product updates[30] - A new strategic initiative has been launched to improve operational efficiency and reduce costs[30] - User data showed a growth in active users, contributing to overall performance improvements[30]

Financial Performance - For the three months ended October 31, 2025, the Company reported a net loss of $1.3 million on sales of $47.6 million, a decrease of approximately 42.3% compared to the prior year [89]. - For the nine months ended October 31, 2025, net income was $9.6 million on sales of $173.5 million, reflecting a decrease of approximately 27.0% compared to the same period last year [94]. Cost and Expenses - Cost of goods sold for the quarter ended October 31, 2025, was 62.0% of net sales, compared to 55.6% in the same quarter last year, resulting in a gross margin decline to 38.0% from 44.4% [90]. - Selling, general and administrative expenses (SG&A) for the three months ended October 31, 2025, were 41.5% of sales, up from 30.9% in the prior year due to lower sales volume [91]. Order and Inventory Management - The Company's order backlog at October 31, 2025, was approximately $26 million, slightly down from $27 million in the prior year, with expectations for most of the backlog to be recognized as revenue in Q4 [84]. - Accounts receivable decreased by $14.4 million at October 31, 2025, primarily due to a decrease in shipments [100]. - Inventory increased by $4.1 million at October 31, 2025, driven by increased costs, despite decreased production levels [100]. Tax and Cash Flow - The effective income tax rate for the three months ended October 31, 2025, was 26.8%, compared to 25.5% in the prior year [93]. - The Company spent $5.1 million on capital expenditures for the nine months ended October 31, 2025, down from $5.4 million in the same period last year [101]. - The Company had approximately $26.5 million in cash at October 31, 2025, compared to $38.9 million in the prior year, with ongoing cash flow used for capital expenditures and stock repurchases [102]. Risks and Market Conditions - The Company has made forward-looking statements regarding its performance and market conditions, which are subject to risks and uncertainties [111]. - Key risks include availability of funding for educational institutions, material costs, labor costs, product demand, competitive conditions, and general economic conditions [111]. - The Company is classified as a smaller reporting company and is not required to provide detailed market risk disclosures [113].

Financial Performance - Fourth-quarter net loss for 2025 was $7.2 million, an improvement from a net loss of $48.3 million in the prior year[3] - Total adjusted EBITDA for the fourth quarter of 2025 was $41.6 million, up from $15.6 million in the prior year[3] - Total company reported adjusted EBITDA for fiscal 2025 was $198.8 million, down 4% year over year, but adjusted EBITDA increased by 4% when excluding the impact of contingent consideration[3] - Adjusted EBITDA for the fiscal year ended September 30, 2025, was reported at $198.8 million, down from $206.3 million in 2024, with a modified adjusted EBITDA of $190.9 million compared to $184.2 million in the previous year[36] - The company reported a net loss of $7.2 million for the three months ended September 30, 2025, compared to a net loss of $48.3 million for the same period in 2024[46] - Adjusted net loss income for the twelve months ended September 30, 2025, was $20.1 million, a significant improvement from an adjusted net income of $3.7 million in 2024[46] Sales and Revenue - Sales for the fiscal year ended September 30, 2025, reached $1,243.9 million, an increase from $1,117.4 million in 2024[43] - The Salt segment revenue for fiscal 2025 was up 13% year over year to $1,022.5 million, driven by a 20% increase in highway deicing sales volumes[8] - Sales for the Salt Segment reached $181.6 million for the three months ended September 30, 2025, up from $162.5 million in the same period of 2024[54] - Sales to external customers for the three months ended September 30, 2025, were $227.5 million, an increase from $208.8 million in the same period of 2024, representing a growth of 9.5%[72] Cost Management and Expenses - The company reduced net total debt by 14%, or $125 million, year over year, to $772.5 million at year-end[5] - Capital expenditures for the twelve months ended September 30, 2025, were $69.7 million, a decrease from $114.2 million in 2024, indicating a focus on cost management[70] - Selling, general and administrative expenses for the three months ended September 30, 2025, totaled $26.4 million, compared to $31.3 million in the same period of 2024, reflecting a decrease of 15.6%[72] - The company recognized restructuring charges of $60.1 million for the fiscal year ended September 30, 2025, which included $4.0 million in corporate and other segments[40] Impairment and Losses - The company incurred total impairment losses of $53.7 million during the fiscal year ended September 30, 2025, compared to $193.4 million in 2024[45] - The company incurred total impairment losses of $53.0 million related to intangible assets and $0.7 million related to long-lived assets during the twelve months ended September 30, 2025[47] - The company recorded an impairment loss of $53.0 million for intangible assets during the twelve months ended September 30, 2025, and $191.0 million for the twelve months ended September 30, 2024[74] Liquidity and Cash Flow - The company ended fiscal 2025 with $59.7 million in cash and cash equivalents and $304.9 million available under its revolving credit facility, totaling $364.6 million in liquidity[15] - Cash and cash equivalents increased to $59.7 million at the end of Q3 2025, compared to $20.2 million at the end of Q3 2024, reflecting improved cash flow from operations[70] Segment Performance - Annual Plant Nutrition sales volumes increased by 19% in 2025 to 326 thousand tons, with profitability improvements due to cost structure reductions[5] - Plant Nutrition Segment sales for Q3 2025 were $41.8 million, a slight decrease from $42.4 million in Q3 2024, while total sales for the twelve months ended September 30, 2025, increased to $206.3 million from $181.0 million in 2024[59] - The operating income for the Plant Nutrition Segment improved to $6.2 million in Q3 2025 from a loss of $29.7 million in Q3 2024, with an operating margin of 14.8% compared to (70.0)% in the prior year[59] - Adjusted EBITDA for the Plant Nutrition Segment was $13.5 million in Q3 2025, significantly better than the adjusted loss of $3.7 million in Q3 2024, resulting in an adjusted EBITDA margin of 32.3%[62] Future Guidance - Guidance for total adjusted EBITDA for 2026 is projected to be between $200 million and $240 million[5] - Salt segment adjusted EBITDA for 2026 is expected to range from $225 million to $255 million, with improvements driven by stronger pricing and lower anticipated per-ton costs[5] - Capital expenditures for fiscal 2026 are expected to be between $90 million and $110 million, allowing for scaling back in the second half if necessary[23]

Financial Performance - Total revenue for Q3 fiscal 2026 was $67.6 million, representing a 4% year-over-year increase[6] - Non-GAAP net income was $7.7 million, or $0.27 per diluted share, compared to $4.6 million, or $0.17 per diluted share in the prior year[6] - Adjusted EBITDA reached a record $8.6 million, growing 50% year-over-year from $5.7 million[6] - Total revenue for the three months ended October 31, 2025, was $67.625 million, a 3.84% increase from $65.127 million in the same period of 2024[25] - Subscription and services revenue increased to $61.953 million, up from $60.135 million year-over-year, representing a growth of 3.02%[25] - Net income for the three months ended October 31, 2025, was $1.393 million, compared to a net loss of $2.364 million in the same quarter of 2024[27] - Non-GAAP net income for the three months ended October 31, 2025, was $7.667 million, up from $4.561 million in the prior year[28] - The company reported a basic net income per share of $0.05 for the three months ended October 31, 2025, compared to a loss of $0.09 per share in the same period of 2024[25] - Total operating income for the three months ended October 31, 2025, was $1.292 million, a significant improvement from an operating loss of $2.286 million in the prior year[28] - Adjusted EBITDA for the nine months ended October 31, 2025, was $22.417 million, compared to $16.344 million in the same period of 2024, indicating a strong operational performance[28] Revenue Projections - The company expects total revenue for Q4 fiscal 2026 to be in the range of $71.3 million to $71.9 million, including an expected contribution from FluentStream of $4.0 million to $4.1 million[7] - For the full fiscal year 2026, total revenue is projected to be between $270.3 million and $270.9 million, with FluentStream contributing $4.0 million to $4.1 million[7] Acquisitions - The company completed the acquisition of FluentStream and is on track to complete the acquisition of Phone.com in late December[4] Cash and Assets - Ooma's cash and cash equivalents increased to $21.7 million as of October 31, 2025, up from $17.9 million at the beginning of the fiscal year[22] - Total assets as of October 31, 2025, were $152.7 million, compared to $149.2 million at the beginning of the fiscal year[22] Operating Expenses - Operating expenses decreased to $39.437 million from $41.556 million year-over-year, a reduction of 5.1%[25] - Gross profit for the three months ended October 31, 2025, was $40.729 million, compared to $39.270 million in the prior year, reflecting a gross margin of 60%[28]

Financial Performance - Virco reported a net loss of $1.3 million in Q3 2025 on sales of $47.6 million, compared to a net profit of $8.4 million on sales of $82.6 million in Q3 2024[2] - Gross profit for Q3 2025 declined to $18.1 million, reflecting a gross margin of 38.0%, down from $36.7 million or 44.4% in the same period last year[2] - Year-to-date sales through nine months decreased by 27.0% to $173.5 million, with net income of $9.6 million compared to $27.4 million in the prior year[7] - Net sales for the three months ended October 31, 2025, were $47,636,000, a decrease of 42.3% compared to $82,620,000 for the same period in 2024[25] - Gross profit for the nine months ended October 31, 2025, was $74,986,000, down 30.0% from $107,243,000 in the prior year[25] - The company reported an operating loss of $1,693,000 for the three months ended October 31, 2025, compared to an operating income of $11,113,000 for the same period in 2024[25] - Net loss for the three months ended October 31, 2025, was $1,325,000, compared to a net income of $8,401,000 in the same quarter of 2024[25] - Basic and diluted net loss per common share for the three months ended October 31, 2025, was $(0.08), compared to earnings of $0.52 per share in the same quarter of 2024[25] Operational Metrics - The company's backlog nearly stabilized year-over-year, with "Shipments Plus Backlog" declining 25% from $265 million to $199 million[8] - Operating expenses (SG&A) decreased to $19.8 million or 41.5% of sales in Q3 2025, compared to $25.6 million or 30.9% of sales in Q3 2024[2] - Selling, general and administrative expenses for the nine months ended October 31, 2025, were $61,402,000, a decrease of 13.8% from $71,265,000 in the prior year[25] - Interest expense for the nine months ended October 31, 2025, was $305,000, down from $506,000 in the same period of 2024[25] Market Conditions - Management noted a significant downturn of approximately 30% in the market for moveable school furniture over the last two years, attributed to the expiration of pandemic recovery stimulus funds[5][6] - Management anticipates a potential recovery in demand similar to post-pandemic trends, although at a lower magnitude[12] - The company is actively exploring opportunities in adjacent public and private markets amid current challenges[15] Liquidity and Dividends - The current ratio improved to 3.98, indicating better liquidity and financial flexibility[10] - The board declared a quarterly cash dividend of $0.025 per share, payable on January 9, 2026[10] - Cash dividends declared per common share increased to $0.025 for the three months ended October 31, 2025, from $0.025 in the same period of 2024[25] Investment Performance - The company experienced an unrealized loss on investment in the trust account of $49,000 for the three months ended October 31, 2025, compared to a gain of $(246,000) in the same period of 2024[25]

Revenue Growth - Total revenue for the third quarter increased by 178% year-over-year, reaching $5.2 million compared to $1.9 million in the same period last year[5] - Recurring service revenue rose by 163% year-over-year, indicating strong growth in long-term contracts with property owners[5] - Revenues for Q3 2025 reached $5,248 million, a significant increase from $1,885 million in Q3 2024, representing a growth of 178%[23] - Gross profit for the nine months ended September 2025 was $4,872 million, compared to $884 million for the same period in 2024, indicating a year-over-year increase of 451%[23] Operational Performance - Adjusted EBITDA for the third quarter was $0.1 million, a significant improvement from a loss of $0.9 million in the prior year[5] - Adjusted EBITDA for Q3 2025 was $129 million, compared to an adjusted EBITDA of $(873) million in Q3 2024, marking a significant turnaround[25] - Operating income for Q3 2025 was $118 million, a recovery from an operating loss of $881 million in Q3 2024[23] - Total operating expenses for the nine months ended September 2025 were $4,943 million, up from $3,065 million in the same period of 2024, representing a 61% increase[23] Unit Growth - Contracted units increased to 32,826 from 25,907 a year earlier, reflecting a growing demand for services[11] - Activated units rose to 16,964 from 6,765 a year earlier, showing progress in onboarding new properties[11] - Billed units increased to 10,710 from 5,171 a year earlier, indicating a rise in revenue-generating units[11] Financial Position - As of September 30, 2025, cash and cash equivalents totaled $0.8 million, up from $0.3 million at the end of 2024[21] - Total assets increased to $9.1 million as of September 30, 2025, compared to $7.7 million at the end of 2024[21] - The company reported a net loss per share of $0.03 for Q3 2025, compared to a net loss per share of $0.27 for Q3 2024[23] IPO and Capital Deployment - The company completed its initial public offering on November 6, 2025, raising approximately $15.0 million in gross proceeds[11] - The company anticipates deploying capital from its recent IPO to expand its sales and marketing team and enhance its Networking-as-a-Service (NaaS) offerings[4] Loss and Expenses - Net loss for Q3 2025 was $168 million, an improvement from a net loss of $970 million in Q3 2024, reflecting a reduction of 83%[25] - Interest expense for the nine months ended September 2025 was $295 million, compared to $185 million in the same period of 2024, indicating a 60% increase[25] - The change in fair value of SAFE liability for Q3 2025 was $(176) million, with no comparable figure in Q3 2024[25] - The weighted average common shares used in computing net loss per share increased to 5,000,000 in Q3 2025 from 3,566,369 in Q3 2024[23]

Financial Performance - Revenue for the three months ended October 31, 2025, was $111,998, a decrease of 1.7% compared to $113,989 for the same period in 2024[19]. - Gross profit for the three months ended October 31, 2025, was $82,795, down from $87,742 in the prior year, reflecting a gross margin of 73.9%[19]. - Operating expenses decreased to $75,015 for the three months ended October 31, 2025, compared to $98,110 in the same period of 2024, a reduction of 23.5%[19]. - Net income for the three months ended October 31, 2025, was $6,136, compared to a net loss of $12,799 for the same period in 2024[19]. - Total revenue for the nine months ended October 31, 2025, was $334.6 million, representing an increase of 8.6% from $307.9 million in the same period of 2024[49]. - For the nine months ended October 31, 2025, Yext reported a net income of $33.7 million, compared to a net loss of $20.7 million for the same period in 2024[31]. - Revenue from North America for the nine months ended October 31, 2025, was $270.6 million, up 10.9% from $244.2 million in 2024[49]. - The company reported a net income of $6.1 million for the three months ended October 31, 2025, compared to a net loss of $12.8 million for the same period in 2024, resulting in a basic net income per share of $0.05[131]. - Non-GAAP net income for the three months ended October 31, 2025, was $17.495 million, an increase from $15.615 million in the same period of 2024[194]. - Adjusted EBITDA for the three months ended October 31, 2025, was $27.220 million, compared to $23.094 million in the same period of 2024, reflecting a growth of 18.4%[194]. Assets and Liabilities - Total assets as of October 31, 2025, were $555,773, down from $610,078 as of January 31, 2025, a decrease of 8.9%[17]. - Total liabilities decreased to $400,601 as of October 31, 2025, from $456,885 as of January 31, 2025, a reduction of 12.3%[17]. - Cash and cash equivalents increased to $139,916 as of October 31, 2025, compared to $123,133 as of January 31, 2025, an increase of 13.6%[17]. - The company’s accumulated deficit improved to $(673,463) as of October 31, 2025, from $(707,120) as of January 31, 2025[17]. - The company’s total stockholders' equity increased to $155,172 as of October 31, 2025, from $153,193 as of January 31, 2025[17]. - As of October 31, 2025, the Company's total marketable securities amounted to $88.2 million, with money market funds comprising $28.4 million[76]. - Accounts payable and accrued expenses totaled $39.030 million as of October 31, 2025, a decrease from $70.022 million as of January 31, 2025[97]. Cash Flow and Financing - Cash provided by operating activities for the nine months ended October 31, 2025, was $26.3 million, compared to $11.9 million in 2024[31]. - Free cash flow for the three months ended October 31, 2025, was $(20.335) million, compared to $(16.372) million in the same period of 2024[199]. - The company reported net cash used in investing activities of $(20,451) thousand for the nine months ended October 31, 2025, compared to $(91,176) thousand in the same period of 2024[214]. - Net cash provided by financing activities was $10.1 million for the nine months ended October 31, 2025, compared to $(13,213) thousand in the same period of 2024[214]. - The company entered into a May 2025 Credit Agreement providing for a senior secured initial term loan facility of up to $100 million, maturing on May 15, 2030[110]. - As of October 31, 2025, the Company's principal debt obligation was $100 million, with a net carrying amount of $98.167 million after accounting for unamortized costs[117]. - The company incurred original issue discount costs of $1.0 million and debt issuance costs of $0.7 million in connection with the May 2025 Credit Agreement[211]. - The May 2025 Credit Agreement requires the company to maintain minimum qualified cash of at least $35.0 million at all times[210]. - As of October 31, 2025, the company was in compliance with all debt covenants[212]. Acquisitions - The company completed the acquisition of Hearsay on August 1, 2024, to enhance its digital presence platform capabilities[57]. - The total consideration transferred for the acquisition of Hearsay amounted to $180.7 million, which includes cash consideration of $132.5 million and contingent consideration of $39.8 million[58][60][61]. - The contingent consideration is tied to an earnout arrangement that could require payments of up to $75.0 million based on achieving specific Annual Recurring Revenue (ARR) milestones by September 2026[61]. - The Company recognized acquisition-related costs totaling $11.2 million, which were expensed as incurred and included $8.8 million related to the incentive pool for Hearsay founders and early employees[65]. - The purchase price allocation for the acquisition of Hearsay included identifiable intangible assets valued at $101.9 million, with customer relationships valued at $76.2 million and technology at $24.8 million[66][70]. - The acquisition of Places Scout was completed for a purchase price of $20.3 million, with $5.6 million allocated to technology and $0.9 million to customer relationships[73][74]. - The Company issued approximately 2.1 million replacement equity awards with a fair value of $11.8 million as part of the Hearsay acquisition, with $7.8 million allocated to pre-acquisition services[62]. - The company completed the acquisition of KabanaSoft for $20.3 million, enhancing its competitive intelligence and AI capabilities[142]. Revenue Recognition and Backlog - As of October 31, 2025, unearned revenue was $154.6 million, indicating a strong backlog of future revenue[54]. - The company had $415.6 million in remaining performance obligations as of October 31, 2025, with $377.1 million expected to be recognized as revenue over the next 24 months[56]. - Revenue from direct customers was $93.3 million for the three months ended October 31, 2025, down $2.2 million or 2% from $95.5 million in 2024, primarily due to customer attrition[166]. - Revenue from direct customers for the nine months ended October 31, 2025, was $279.2 million, an increase of $27.1 million or 11% from $252.2 million in 2024[176]. - Total Annual Recurring Revenue (ARR) decreased by 1% to $444.36 million in 2025 from $448.65 million in 2024[151]. Stock-Based Compensation - Stock-based compensation expense for the nine months ended October 31, 2025, was $38.0 million, slightly up from $37.1 million in 2024[31]. - Total stock-based compensation expense for the three months ended October 31, 2025, was $12.338 million, a decrease of 2.8% from $12.693 million in the same period of 2024[99]. - For the nine months ended October 31, 2025, total stock-based compensation expense increased to $37.959 million, up 2.3% from $37.091 million in 2024[99]. - The balance of restricted stock and restricted stock units (RSUs) as of October 31, 2025, was 8,857,312, with a weighted-average grant date fair value of $7.30[102]. - The Company granted 1,025,000 performance-based restricted stock units (PSUs) during the nine months ended October 31, 2025, which vest based on achieving specific metrics[103]. Tax and Compliance - The Company recorded a provision for income taxes of $0.5 million for the three months ended October 31, 2025, compared to $3.0 million for the same period in 2024[120]. - The effective tax rate differs from the U.S. federal statutory tax rate primarily due to full valuation allowances related to net deferred tax assets[121]. - The projected tax rate for non-GAAP income was updated to 25.5% for fiscal year 2026, compared to 25% in fiscal year 2025[187]. Market Conditions and Strategic Initiatives - Macroeconomic conditions, including inflation and foreign currency fluctuations, may adversely impact the company's financial condition and operating results in future periods[139]. - Michael Walrath, CEO of Yext, proposed to acquire all outstanding shares at $9.00 per share, with no decision made yet by the Board[141]. - The company operates as a single segment, with consolidated net income (loss) used to measure segment profit or loss[132]. - The company’s digital presence platform, known as the Answers Platform, is utilized by over 200 service and application providers, enhancing its market reach[135].

Financial Performance - Consolidated net sales for Q1 FY 2026 were $120.5 million, a 6% decrease from $127.9 million in Q1 FY 2025[4] - Net income for Q1 FY 2026 was $15.5 million, down 6% from $16.4 million in the same period last year[13] - EBITDA for Q1 FY 2026 totaled $23.6 million, reflecting a 10% decrease compared to $26.2 million in Q1 FY 2025[11] - The B2B Products Group reported revenues of $44.3 million, a 9% decline from the prior year's record levels[15] - The R&W Products Group's revenues were $76.2 million, down 4% from the previous year's record, driven by a decline in volume[17] - Gross profit for Q1 FY 2026 was $35.5 million, representing a 13% decline from the prior year, with gross margins at 29.5%[8] - Net sales for the three months ended October 31, 2025, were $120,486, a decrease of 5.7% compared to $127,945 in the same period of 2024[31] - Gross profit margin decreased to 29.5% in Q1 2025 from 31.9% in Q1 2024, with gross profit amounting to $35,495 compared to $40,780[31] - Net income for Q1 2025 was $15,456, a decline of 5.6% from $16,376 in Q1 2024, maintaining a net income margin of 12.8%[31] - EBITDA for Q1 2025 was $23,641, down from $26,167 in Q1 2024, indicating a decline of 9.7%[37] Expenses and Liabilities - Selling, general and administrative expenses decreased by 5% to $18.5 million compared to $19.6 million in the same period last year[9] - Operating income for the B2B Products Group was $13.6 million, down 20% from $17.1 million in Q1 FY 2025[16] - Total current assets decreased to $170,076 as of October 31, 2025, from $177,383 as of July 31, 2025[33] - Total liabilities decreased to $114,196 as of October 31, 2025, from $132,617 as of July 31, 2025[33] Cash Flow and Dividends - Cash and cash equivalents at the end of Q1 FY 2026 totaled $42.4 million, down from $50.5 million at the end of FY 2025[14] - Cash and cash equivalents decreased to $42,384 from $50,458, reflecting a net decrease of $8,074 in cash during the quarter[35] - The company paid dividends of $2,444 in Q1 2025, compared to $2,096 in Q1 2024, representing an increase of 16.6%[35] - The company reported a decrease in accounts receivable by $3,077, improving cash flow from operations[35] Sales Performance - Domestic cat litter sales, excluding co-packaging, were $56.2 million, a 6% decline year-over-year[18] - Cash and cash equivalents decreased to $42,384 from $50,458, reflecting a net decrease of $8,074 in cash during the quarter[35] - The book value per share outstanding increased to $19.14 from $18.76, reflecting a growth of 2.0%[33]

Clinical Trials and Research - MiNK Therapeutics reported a median overall survival of approximately 23 months for patients receiving agenT-797 in combination with PD-1 therapies, significantly exceeding the expected survival of under six months in a refractory setting [7]. - The company observed a complete remission in a patient with metastatic testicular cancer lasting over two years following a single infusion of agenT-797 combined with PD-1 blockade [26]. - The company is preparing for a global Phase II trial in acute pulmonary dysfunction, with the study expected to launch within weeks [19]. - The Phase I study of agenT-797 demonstrated durable activity across various tumor types, with nearly half of patients having failed PD-1 ligand inhibitors [25]. - The primary endpoint for the pulmonary disease trial will be 28-day mortality, with additional secondary and exploratory endpoints being established [71]. - The company anticipates launching the severe pulmonary disease trial with the first patient targeted for enrollment by early Q1 of next year [54]. - The GvHD trial is funded through a partnership with government collaborators and aims to improve engraftment success without the need for cytotoxic lymphodepletion [60]. - The GvHD program aims for a significant reduction in GvHD incidence, targeting a 50% improvement or more, which would be substantially beneficial [63]. - MiNK Therapeutics aims to redefine immune recovery in cancer and critical illness, focusing on reeducating the immune system rather than suppressing it [35]. - The company is actively engaging with the FDA to ensure rapid development pathways for its clinical programs [64]. Financial Performance - The cash balance at the end of Q3 2025 was $14.3 million, with an additional $1.2 million raised since the quarter end, providing a runway through 2026 [36]. - The net loss for Q3 2025 was $2.9 million, or $0.65 per share, compared to a net loss of $1.8 million, or $0.46 per share, for Q3 2024 [36]. - For the nine months ended September 30, 2025, the net loss was $9.9 million or $2.39 per share, compared to a net loss of $8.3 million or $2.24 per share for the same period in 2024 [38]. - The company executed an at-the-market sales agreement, leveraging a more than 700% increase in equity price, which extended the cash runway through 2026 [42]. - The company is exploring nondilutive financing options to expand its manufacturing infrastructure beyond current capabilities [76]. Partnerships and Collaborations - The company has established a strategic partnership with the University of Wisconsin to advance its iNKT program in immune reconstitution following stem cell transplantation [15]. - The company is leveraging public-private partnerships, including support from the Department of Defense and NIH, to advance its clinical programs with minimal capital impact [17]. - Discussions are ongoing with collaborators in both the private and public sectors to leverage substantial scale and interest [79]. Manufacturing and Production - The company is currently able to produce 1 billion cells per donor, which provides substantial cost advantages and the ability to stockpile materials for trials [76]. - The cells have demonstrated stability for almost 3 years, indicating potential for continued production at scale [77]. - The company is preparing for future opportunities based on the current stability of their products [77].

EXHIBIT 99.1 Yext Announces Third Quarter Fiscal 2026 Results NEW YORK -- (BUSINESS WIRE) — December 8, 2025 — Yext, Inc. (NYSE: YEXT), the leading brand visibility platform, today announced its results for the three months ended October 31, 2025, or Yext's third quarter of fiscal year 2026. The Yext Board of Directors and its Special Committee continues to work with its advisors to carefully review and consider Michael Walrath's non-binding proposal to acquire the company, as well as any other strategic al ...